Atlas FDA

VNS Therapy System

FDA premarket approval P970003/S213 · decided 2017-08-11

Approval details

PMA number
P970003
Supplement
S213
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
VNS Therapy System
Generic name
Stimulator, autonomic nerve, implanted for epilepsy
Applicant
LivaNova USA, Inc.
Date received
2017-07-19
Decision date
2017-08-11
Days to decision
23 days
Decision code
OK30
Product code
LYJ
Advisory committee
Neurology
Expedited review
No
Location
Houston, TX
Statement
Removal of a redundant generator interrogation inspection and a redundant sterilization inspection from the shipping process.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Venous Return Cannulae (K250937)LivaNova USA, Inc.2026-03-11
RAP Femoral Venous Cannulae (K250283)LivaNova USA, Inc.2025-07-10
SMARxT Tubing and Connectors (K233702)LivaNova USA, Inc.2024-08-08